Group 1: Shareholder and Buyback Activities - Shareholder Lu Yin Investment's buyback plan has exceeded the lower limit of CNY 125 million, with a target upper limit of CNY 250 million [1] - The company is progressing with a buyback plan of CNY 100 million to CNY 200 million, aimed at reducing registered capital and enhancing earnings per share [1] - The restricted stock incentive plan involves the buyback and cancellation of 7,009,780 shares, currently undergoing creditor announcement procedures [1] Group 2: Strategic Partnerships and Collaborations - The company signed a project cooperation letter of intent with Sinopec Catalyst Co., which will facilitate resource sharing and technical complementarity, aiming for product collaboration in the petrochemical catalyst field by 2025 [3] Group 3: Production Expansion Plans - The company plans to invest no more than CNY 300 million in the C05 project for semiconductor materials and polyimide materials, with a theoretical production capacity exceeding 1,000 tons [4] - Current semiconductor material production capacity is fully utilized, and the project is in the preparatory phase, expected to take about two years for completion after obtaining necessary approvals [4] Group 4: Performance and Project Updates - The company's second-quarter performance will be disclosed in the half-year report scheduled for August 22 [5] - The "Zhongjie Neng Wanrun (Penglai) New Materials Phase I Construction Project" has begun trial production of semiconductor materials, with further product launches dependent on trial progress and downstream customer validation [6][7] Group 5: Research and Development Focus - The company is focusing on material research in solid-state batteries, with no plans to produce batteries, and is currently developing high-purity materials in collaboration with universities [7] - The company is actively developing high-performance polymer products, including thermoplastic polyimide and polyether ether ketone, with some products already in sales and others in market promotion and validation stages [7]

Group 1 - The company Tianshan Electronics has increased its share buyback efforts this year, repurchasing a total of 2.6339 million shares, which accounts for 1.3331% of its total share capital, with a total transaction amount of 59.9967 million yuan [2] - The buyback was conducted at a maximum price of 29.32 yuan per share and a minimum price of 18.75 yuan per share, remaining within the previously set price limits [2] - The company stated that the buyback reflects management's confidence in future development and aims to enhance investor confidence and protect shareholder interests [2] Group 2 - Tianshan Electronics has been deeply involved in the customized LCD display industry for 20 years, offering products such as monochrome LCD displays, color LCD modules, and touch screens [3] - The company has established a long-term strategic partnership with Shentianma, producing over 5,000 types of display application products, serving major clients like LG, BYD, and Panasonic [3] - Tianshan Electronics focuses on vertical integration of the display industry chain and aims to penetrate markets in automotive displays, smart home applications, and emerging Southeast Asian markets [3]

证券研究报告/投资策略 机构调研、股东增持与公司回购策略周报（20250526-20250530） 投资要点 ➢ 机构调研热门公司梳理 近30天机构调研数前二十的热门公司有大族激光、周大生、曼卡龙、斯迪克、汇 川技术等。近5天机构调研数前二十的热门公司有大族激光、三友联众、周大生、 能辉科技、斯迪克等。近30天机构调研数前二十的热门公司中评级机构家数大于 或等于10家的有3家，分别为周大生、汇川技术和深南电路。深南电路、台华新 材、大族激光2024年归母净利润相较2023年实现较大增长。 ➢ 本周A股上市公司重要股东增持情况 2025年5月26日至2025年5月30日，发布重要股东增持进展情况公告的公司共计 2家，分别为中国黄金和新华医疗，拟增持金额上下限均值占最新公告日市值比 例分别为1.76%和1.61%。 ➢ 本周A股上市公司回购情况 ➢ 2025/01/01-2025/05/30部分上市公司回购情况 2025年1月1日至5月30日，共计1491家公司发布回购进展情况公告，评级机 构家数大于10家（含10家）的共329家公司，其中回购比例较大，预计回购 金额上下限均值占预案日市值比例大于1%的有99家， ...

Overview - Since the beginning of 2025, the A-share market has maintained a slight net inflow of funds, with the annual net inflow accounting for 1.1% of the free float market value as of May 22, 2025. Excluding private equity and insurance funds, the net outflow is approximately 0.1%, indicating a tight balance in the funding situation for the year [7][8][9]. Monthly Trends - In April 2025, there was a slight net outflow of funds amounting to 778 million, representing 0.01% of the circulating market value. However, in May, the situation improved with a net inflow of 1942 million, raising the net inflow ratio to 0.5% [13][17]. - The financing balance saw a significant decrease in April, dropping by 1226.21 million, but rebounded slightly in May with an increase of 211.58 million [18][19]. Fund Inflows and Outflows - In April 2025, the stock-type ETF saw a substantial net inflow of 1876.9 million, but turned to a net outflow of 422.95 million by May 22. Overall, the ETF funds recorded a net inflow of 506 million for the year [13][18]. - Insurance funds are expected to increase further, with the balance of insurance company investments reaching 349312.14 billion, an increase of 16731.92 billion from the previous quarter [18][19]. Company Actions - The total amount of share buybacks announced by listed companies in April 2025 was 1588.09 million, significantly higher than in March. By May 22, the cumulative buyback amount for the year reached 4095.64 million [18][19]. - The dividend payout in April 2025 was notably strong, with the dividend rate remaining at historically high levels [19]. Equity Financing - The scale of equity financing continued to decline, with April's financing amount at 432.06 million, a slight decrease from March. By May 22, the financing scale was recorded at 80.16 million, indicating a low level [19].

证券研究报告/投资策略 机构调研、股东增持与公司回购策略周报（20250512-20250518） 投资要点 ➢ 机构调研热门公司梳理 近30天机构调研数前二十的热门公司有华明装备、雅戈尔、曼卡龙、中际联合、 泰和新材和塞恩斯等。近5天机构调研数前二十的热门公司有泰和新材、星帅尔、 农产品、国脉科技、雅化集团和东方嘉盛等。近30天机构调研数前二十的热门公 司中评级机构家数大于或等于10家的有7家，分别为华明装备、中际联合、周大 生、伟星新材、怡和嘉业、华利集团和小商品城。华明装备、中际联合、华利集 团和小商品城2024年归母净利润相较2023年实现较大增长。 ➢ 本周A股上市公司重要股东增持情况 2025年5月5日至2025年5月9日，发布重要股东增持进展情况公告的公司共计13 家，评级机构家数大于10家（含10家）的有3家，拟增持金额上下限均值占最新 公告日市值比例大于1%的共5家，分别为*ST庚星、海南发展、中铁工业、华懋科 技和玲珑轮胎。 ➢ 本周A股上市公司回购情况 2025年5月12日至2025年5月16日，共计109家公司发布回购进展情况公告，评 级机构家数大于10家（含10家）的共20家公司，其 ...

Group 1: Institutional Research on Popular Companies - The top twenty companies with the highest number of institutional research visits in the past 30 days include Huaming Equipment, Changshu Bank, Guangdian Yuntong, Yunnan Baiyao, and BYD. In the last five days, the most visited companies were Mankalon, Zhou Dasheng, Stable Medical, Zhujiang Beer, and Shenghe Resources. Among the top twenty companies in the past 30 days, 11 companies had 10 or more rating agencies, including BYD, Huali Group, Weixing New Materials, Changshu Bank, and Weixing Co., Ltd. [2][11][12] - Companies such as BYD, Huali Group, Changshu Bank, Weixing Co., Ltd., Weichai Power, Yunnan Baiyao, Tuobang Co., Ltd., Huaming Equipment, and Zhongji United are expected to see significant growth in net profit attributable to shareholders in 2024 compared to 2023 [2][11][12]. Group 2: Shareholder Increase Activities - From May 5 to May 9, 2025, a total of 13 companies announced significant shareholder increases, with three companies having 10 or more rating agencies. The companies with an average proposed increase amount exceeding 1% of the latest market value include *ST Gengxing, Hainan Development, China Railway Industry, Huamao Technology, and Linglong Tire [3][14][15]. - From January 1 to May 11, 2025, 297 companies announced significant shareholder increases, with 203 having 10 or more rating agencies. Among these, 15 companies had an average proposed increase amount exceeding 1% of the latest market value, including Xinjie Energy, Sailun Tire, Rongsheng Petrochemical, Wanrun Co., Ltd., CNOOC Engineering, and Xin Fengming [5][16][17]. Group 3: Company Buyback Activities - From May 5 to May 9, 2025, a total of 312 companies announced buyback progress, with 84 companies having 10 or more rating agencies. Companies expected to have a buyback amount exceeding 1% of the market value on the announcement date include Pingmei Co., Ltd., Huafa Co., Ltd., Changhong Meiling, XGIMI Technology, and Xugong Machinery [4][19][20]. - From January 1 to May 11, 2025, 1,456 companies announced buyback progress, with 297 having 10 or more rating agencies. Among these, 82 companies had a buyback amount exceeding 1% of the market value on the announcement date, including Changhong Meiling, Qianwei Central Kitchen, Baolong Technology, Shantui Co., Ltd., Wanrun Co., Ltd., Midea Group, BOE A, and Goldwind Technology [6][22][23].

这张截图来自明讯创始人的朋友圈，我最开始于 3 月 20 日发布在我的公众号里。 关于初创公司 - 明讯科技，和投资机构 - 同创 wy 的纠纷，不知还有多少人不了解背景。 我当时发布的文章，除了这张截图外，还有来自鲸准 app 的，同创投资明讯的截图。除此之外，没有我的原创内容。 然后， 20 日下午，同创发出一则公告，称明讯创始人的指控严重不实，同时也要求各自媒体删除相关内容。 同时，创始人也删除了朋友圈的内容。于是，我也删了我的文章。 有小伙伴问我删掉的那篇是什么内容，为什么删掉，我在此做个补充解释。 关于这份纠纷，公众号"创投日报"于 3 月 22 日发布了对明讯创始人的专访，比较真实全面的还原了事件过程。 我在 3 月 31 日发布的《回购的真实模样》，也部分是在为这件事，为创始人发声。 在我眼里，大部分创始人在投资机构面前是相对弱势的一方，是信息不对称的一方， 而且，我曾按合伙人的指示，亲手在回购和落地等事项上，让初创企业元气大伤，让企业新一轮难以为继。 我的价值观让我不得不为创始人发声。如果我有偏颇，有说的不对的地方，我承认。我毕竟只是一个个人公众号。 然后，在《回购的真实模样》的评论里我有提到 ...

Core Viewpoint - The company held its 2024 annual performance online briefing, where it faced numerous investor questions but did not provide responses to most inquiries, indicating a lack of transparency or communication strategy during challenging times [1][2][3]. Financial Performance - In 2024, the company achieved a revenue of 3.03 billion yuan and a net profit of 1.96 billion yuan, reflecting a year-on-year growth of 5.5% and 5.3% respectively [16]. - The company reported a significant decline in revenue and profit in the fourth quarter of 2024, raising concerns among investors about future performance [2][3]. Market Strategy - The company is focusing on international expansion, with plans to leverage the acquisition of REGEN Biotech, Inc. to enhance its global presence [18]. - The company is committed to maintaining its core business and improving product offerings without diversifying into downstream operations [11][19]. Product Development - A new product, a medical-grade polyvinyl alcohol gel microsphere, has received regulatory approval and is expected to launch in 2025 [6][22]. - The company is in the process of developing several products, including botulinum toxin, which is currently in the registration phase [14][22]. Investor Relations - The company received 43 questions from investors during the briefing but only answered 27, resulting in a response rate of 62.79% [1]. - Investors expressed concerns about stock buybacks and the need for measures to boost confidence amid declining stock prices [2][4].